Sörenson S, Bake B
Eur J Cancer Clin Oncol. 1984 Jan;20(1):61-7. doi: 10.1016/0277-5379(84)90035-x.
Regional lung function was studied in 21 patients with small cell bronchogenic carcinoma who demonstrated a complete radiographic regression of intrathoracic tumour after 3 months of combination chemotherapy. Spirometry was performed in 20 patients. VC and FEV1 were, on average, 89 and 88% of predicted normal values. Impairment of ventilation and/or perfusion at the site of previous tumour was documented in 13 patients, while no such abnormalities were observed in 8 cases. Reduction of blood flow was generally more severe than impairment of ventilation. Neither median survival nor disease-free 2-yr survival was improved in patients with normal regional lung function compared to patients with functional impairment. This lack of survival advantage suggests that factors other than persistent tumour, such as scar formation, may contribute to reduction of regional lung function after chemotherapy for small cell bronchogenic carcinoma.
对21例小细胞支气管肺癌患者的局部肺功能进行了研究,这些患者在接受3个月联合化疗后,胸部肿瘤在影像学上完全消退。对20例患者进行了肺活量测定。肺活量(VC)和第一秒用力呼气容积(FEV1)平均分别为预测正常值的89%和88%。13例患者记录到先前肿瘤部位存在通气和/或灌注受损,而8例未观察到此类异常。血流减少通常比通气受损更严重。与肺功能受损的患者相比,局部肺功能正常的患者的中位生存期和2年无病生存期均未改善。这种生存优势的缺乏表明,除了持续存在的肿瘤外,诸如瘢痕形成等因素可能导致小细胞支气管肺癌化疗后局部肺功能下降。